From: Gamma knife radiosurgery for the treatment of uveal melanoma and uveal metastases
 | Melanoma | Metastases |
---|---|---|
Age at gamma knife (years) | 76.9 ± 10.0 | 59.0 ± 12.8 |
Female (%) | 63.6 | 28.5 |
Length of follow-up (months) | 19.74 ± 10.4 | 6.03 ± 6.32 |
Survival (%) | 72.7 | 14.3 |
Tumor recurrence (% recurrence) | 0 | 28.6 |
Pre-op tumor thickness by ultrasound (mm) | 5.30 ± 2.17 | 3.50 ± 1.36 |
Post-op tumor thickness by ultrasound (mm) | 3.60 ± 2.32 | 1.30 ± 0.76 |
Pre-op VA (logMAR/Snellen) | 0.30 ± 0.53/20/40 | 0.30 ± 0.59/20/40 |
Pre-op IOP (mmHg) | 14.0 ± 2.40 | 14.0 ± 7.31 |
VA at last follow-up (logMAR/Snellen) | 0.40 ± 0.97/20/50 | 0.30 ± 1.57/20/40 |
IOP at last follow-up (mmHg) | 15.0 ± 3.49 | 17.0 ± 3.39 |
Enucleation (%) | 9.09 | 14.3 |
Largest base dimension pre-op (mm) | 19.9 ± 4.55 | 14.0 ± 5.55 |
Largest base dimension post-op | 17.6 ± 1.90 | 13.50 ± 9.62 |